328 related articles for article (PubMed ID: 18986531)
1. Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year randomized study.
Engvall IL; Svensson B; Tengstrand B; Brismar K; Hafström I;
Arthritis Res Ther; 2008; 10(6):R128. PubMed ID: 18986531
[TBL] [Abstract][Full Text] [Related]
2. Low-dose prednisolone in early rheumatoid arthritis inhibits collagen type I degradation by matrix metalloproteinases as assessed by serum 1CTP--a possible mechanism for specific inhibition of radiological destruction.
Engvall IL; Svensson B; Boonen A; van der Heijde D; Lerner UH; Hafström I;
Rheumatology (Oxford); 2013 Apr; 52(4):733-42. PubMed ID: 23275387
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
[TBL] [Abstract][Full Text] [Related]
4. Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study.
Hafström I; Albertsson K; Boonen A; van der Heijde D; Landewé R; Svensson B;
Ann Rheum Dis; 2009 Apr; 68(4):508-13. PubMed ID: 18420939
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing bone loss in rheumatoid arthritis: a longitudinal study.
Cortet B; Guyot MH; Solau E; Pigny P; Dumoulin F; Flipo RM; Marchandise X; Delcambre B
Clin Exp Rheumatol; 2000; 18(6):683-90. PubMed ID: 11138329
[TBL] [Abstract][Full Text] [Related]
6. Changes in bone mineral density in premenopausal women with rheumatoid arthritis during a two-year follow-up.
Hämäläinen H; Kaarela K; Kröger H; Kauppi M; Järvenpää S; Hakala M; Kotaniemi A
Joint Bone Spine; 2007 Oct; 74(5):482-7. PubMed ID: 17905634
[TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of formation (PINP) and resorption (Ctx) bone turnover markers in rheumatoid arthritis.
Wisłowska M; Jakubicz D; Stepień K; Cicha M
Rheumatol Int; 2009 Oct; 29(12):1403-9. PubMed ID: 19219607
[TBL] [Abstract][Full Text] [Related]
8. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.
Lange U; Teichmann J; Müller-Ladner U; Strunk J
Rheumatology (Oxford); 2005 Dec; 44(12):1546-8. PubMed ID: 16263785
[TBL] [Abstract][Full Text] [Related]
9. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
10. Abatacept might increase bone mineral density at femoral neck for patients with rheumatoid arthritis in clinical practice: AIRTIGHT study.
Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Koike T
Rheumatol Int; 2018 May; 38(5):777-784. PubMed ID: 29294175
[TBL] [Abstract][Full Text] [Related]
11. Bone turnover, joint damage and bone mineral density in early rheumatoid arthritis treated with combination therapy including high-dose prednisolone.
Verhoeven AC; Boers M; te Koppele JM; van der Laan WH; Markusse HM; Geusens P; van der Linden S
Rheumatology (Oxford); 2001 Nov; 40(11):1231-7. PubMed ID: 11709606
[TBL] [Abstract][Full Text] [Related]
12. Hand bone loss measured by digital X-ray radiogrammetry is a predictor of joint damage in early rheumatoid arthritis.
Forslind K; Boonen A; Albertsson K; Hafström I; Svensson B;
Scand J Rheumatol; 2009; 38(6):431-8. PubMed ID: 19922017
[TBL] [Abstract][Full Text] [Related]
13. Reducing glucocorticoid dosage improves serum osteocalcin in patients with rheumatoid arthritis-results from the TOMORROW study.
Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Koike T; Nakamura H
Osteoporos Int; 2016 Feb; 27(2):729-35. PubMed ID: 26294294
[TBL] [Abstract][Full Text] [Related]
14. Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone.
Garnero P; Thompson E; Woodworth T; Smolen JS
Arthritis Rheum; 2010 Jan; 62(1):33-43. PubMed ID: 20039425
[TBL] [Abstract][Full Text] [Related]
15. Randomized withdrawal of long-term prednisolone treatment in rheumatoid arthritis: effects on inflammation and bone mineral density.
Tengstrand B; Larsson E; Klareskog L; Hafström I
Scand J Rheumatol; 2007; 36(5):351-8. PubMed ID: 17963164
[TBL] [Abstract][Full Text] [Related]
16. Osteogenesis and osteoclast inhibition in rheumatoid arthritis patients treated with bisphosphonates alone or in combination with pitavastatin over an 18-month follow-up after more than 4 years of treatment with bisphosphonates.
Nagashima M; Takahashi H; Shimane K; Nagase Y; Wauke K
Arthritis Res Ther; 2012 Oct; 14(5):R224. PubMed ID: 23079134
[TBL] [Abstract][Full Text] [Related]
17. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.
Grinspoon S; Baum H; Lee K; Anderson E; Herzog D; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):3864-70. PubMed ID: 8923830
[TBL] [Abstract][Full Text] [Related]
18. Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis.
Chen YM; Chen HH; Huang WN; Liao TL; Chen JP; Chao WC; Lin CT; Hung WT; Hsieh CW; Hsieh TY; Chen YH; Chen DY
PLoS One; 2017; 12(11):e0188454. PubMed ID: 29155868
[TBL] [Abstract][Full Text] [Related]
19. Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis.
Landewé R; Geusens P; Boers M; van der Heijde D; Lems W; te Koppele J; van der Linden S; Garnero P
Arthritis Rheum; 2004 May; 50(5):1390-9. PubMed ID: 15146408
[TBL] [Abstract][Full Text] [Related]
20. Generalized bone loss in early rheumatoid arthritis patients followed for ten years in the biologic treatment era.
Haugeberg G; Helgetveit KB; Førre Ø; Garen T; Sommerseth H; Prøven A
BMC Musculoskelet Disord; 2014 Sep; 15():289. PubMed ID: 25182527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
